Page 1360 - Cote clinical veterinary advisor dogs and cats 4th
P. 1360

Necrotizing Fasciitis   685


           RISK FACTORS                         DIAGNOSIS                           ○   Negative-pressure wound therapy has
           Injury, such as a bite wound or motor vehicle   Diagnostic Overview        been used  successfully  as an additional
  VetBooks.ir  CONTAGION AND ZOONOSIS          A presumptive diagnosis is made when soft-  •  IV  antibiotics:  beta-lactamase–resistant   Diseases and   Disorders
                                                                                      management tool.
           accident
                                               tissue pain is disproportionate to evident trauma
                                                                                    antibiotics are generally effective against S.
           The risk of zoonosis is low, but humans can have
                                                                                    therapy may be superior due to the risk of
                                               On palpation and probing of the affected area,
           the same clinical disease caused by the same/  and subcutaneous tissues can be easily dissected.   canis; initially broad-spectrum antimicrobial
           similar organisms. Considering the potential   a lack of resistance of affected fascial planes   polymicrobial infections.
           severity of disease, good hygiene practices   is characteristic. Fractures as a source of pain   ○   Clindamycin  11 mg/kg  IV  q  12h;
           should be employed, especially in cases of   are ruled out with radiographs. Confirmation   clindamycin is considered a drug of choice
           broken skin or mucous membrane contact.   requires bacterial culture and histopathology,   for human necrotizing fasciitis, or
           Risk may be increased for immunocompromised    but treatment must be instituted before results   ○   Cefoxitin 30 mg/kg IV q 6h, or
           individuals.                        of these tests are available.        ○   Cefazolin or ampicillin/sulbactam 22 mg/
                                                                                      kg IV q 6h plus enrofloxacin 20 mg/kg
           ASSOCIATED DISORDERS                Differential Diagnosis                 IV q 24h (dogs) or 5 mg/kg q 24h (cats);
           Toxic shock syndrome                •  Cellulitis                          alternatively, cefazolin or ampicillin/
                                               •  Subcutaneous abscess, seroma, or hematoma  sulbactam as above plus amikacin 20 mg/
           Clinical Presentation               •  Soft-tissue or orthopedic trauma    kg IV q 24h (dogs and cats)
           DISEASE FORMS/SUBTYPES               ○   Fractures                       ○   Enrofloxacin may be associated with
           Type II (single-organism) infections of beta-  ○   Blunt trauma            increased risk of streptococcal toxic shock
           hemolytic group G Streptococcus predominate   ○   Bites                    syndrome and should be used with caution
           in dogs, but other causative agents have been   ○   Penetrating projectiles (e.g., gunshot)  when Streptococcus species are suspected
           identified.                         •  Envenomation, especially snake bite  in necrotizing fasciitis.
                                                                                  •  Hyperbaric oxygen therapy and pentoxofyl-
           HISTORY, CHIEF COMPLAINT            Initial Database                     line (15-30 mg/kg PO q8-12h) may improve
           Many patients have a history of penetrating   •  CBC, serum biochemistry profile, urinalysis  outcome and assist with wound management.
           trauma,  but  cases  have  also  been  reported   ○   Nonspecific abnormalities consistent with   •  Aggressive analgesia, titrated to need
           after vaccination and nonpenetrating wounds.   severe inflammation (e.g., neutrophilic   ○   Opioids  (e.g.,  morphine  sulfate  0.05-
           Swelling and lameness may be noted by     leukocytosis with left shift)    0.15 mg/kg/h IV constant rate infusion
           owner.                              •  Radiographs  of  affected  areas  to  rule  out   or buprenorphine 0.02 mg/kg IV q 6h)
           •  Concurrent sepsis results in typical clinical   fractures and other lesions as causes of pain  combined with a nonsteroidal antiinflam-
             signs: anorexia, depression, lethargy, and   •  Advanced or septic cases have abnormalities   matory drug (NSAID) such as carprofen
             weakness,  leading  to  hypotension,  shock,   consistent with sepsis and/or disseminated   2.2 mg/kg  SQ  or  PO  q  12h  unless
             and multiorgan failure (p. 907)    intravascular coagulation (DIC [p. 269]).  contraindicated
           •  Clinical  disease  is  acute  and  rapidly                            ○   Previous concerns that NSAIDs caused
             progressive                       Advanced or Confirmatory Testing       poorer outcomes in humans was not sub-
                                               Cytology of fluids or affected tissues may reveal   stantiated in prospective and retrospective
           PHYSICAL EXAM FINDINGS              exudate with cocci in pairs or chains in cases   studies.
           •  Signs  include  localized  heat,  swelling,   with Streptococcus, increasing clinical suspicion
             erythema, and pain (severe).      for the disease. Diagnostic confirmation is made   Chronic Treatment
             ○   Muscle bellies may be hard and severely   by histopathology and culture of the causative   Chronic wound management may be needed.
               painful on palpation.           organism, but treatment must be instituted
           •  Skin  is  variously  affected,  ranging  from   before these results are available.  Nutrition/Diet
             normal to soft and exudative to an                                   Enteral feeding is preferred over parenteral
             erythematous/blackened eschar      TREATMENT                         unless  contraindicated.  Feed  twice  the  basal
           •  Limb involvement is commonly reported in                            requirements.
             dogs.                             Treatment Overview
           •  Systemic signs include fever, tachycardia, and   Immediate, aggressive treatment consists of wide   Drug Interactions
             dehydration.                      surgical excision of affected tissue, appropriate   NSAIDs: avoid in septic shock or dehydrated
                                               antimicrobial therapy, intensive pain manage-  animals
           Etiology and Pathophysiology        ment, and medical therapy for shock and sepsis
           •  Causative  organism:  Lancefield  group  G,   if present.           Possible Complications
             beta-hemolytic Streptococcus consistent; Strep-                      Delaying  treatment  waiting  for  diagnos-
             tococcus canis is most commonly cultured.   Acute General Treatment  tic results or not treating aggressively
             Staphylococcus pseudintermedius, Clostridium   •  Immediate aggressive treatment for SIRS and   enough increases risk of sepsis, SIRS, and
             spp,  Pasteurella multocida, Pseudomonas   septic shock, if present (p. 907)  death.
             aeruginosa, and other bacteria have been   •  Early, aggressive surgical debridement
             reported to cause necrotizing fasciitis.  ○   Immediate owner consent for amputation   Recommended Monitoring
           •  Bacterial  exotoxins  and  proteases  cause   for limb infections; guarded prognosis and   •  Monitor patients for septic shock, DIC, and
             tissue destruction/necrosis and clinical    risk of reoperation should be discussed  infection progression that would warrant
             signs.                             ○   Debridement of all necrotic and   further debridement.
           •  An  extremely  rapid  course  of  progres-  questionable tissue and drainage (often   •  Monitor bandages for amount and character
             sion (line of tissue inflammation/edema   by  fasciotomy)  are  indicated;  copious   of exudate.
             visibly advances over minutes to hours)   surgical lavage with warm isotonic fluids
             is a hallmark of necrotizing fasciitis,   ± chlorhexidine 0.05%       PROGNOSIS & OUTCOME
             ultimately leading to sepsis and/or the   ○   Wet-to-dry bandaging until infection is
             systemic inflammatory response syndrome    controlled; the bandage should contain a   Surgical delay, incomplete debridement, and
             (SIRS).                              thick absorptive layer.         concurrent sepsis are negative prognostic factors.

                                                      www.ExpertConsult.com
   1355   1356   1357   1358   1359   1360   1361   1362   1363   1364   1365